celecoxib
FDA Approved
Description
Celecoxib is a selective COX-2 inhibitor NSAID used to treat pain and inflammation. It is particularly useful in chronic inflammatory conditions affecting joints and bones. In rare skeletal dysplasias and congenital anomalies, it may help manage chronic pain with potentially fewer gastrointestinal side effects than traditional NSAIDs.
Indications & Therapeutic Use
osteoarthritis, rheumatoid arthritis, pain, inflammation, musculoskeletal disorders
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
celecoxib
| Generic Name | celecoxib |
| Brands | 1 brand available |
| Active Ingredient | celecoxib |
| Drug Class | osteoarthritis |
| Manufacturer | Pfizer |
| Dosage Forms | oral capsule 50mg, 100mg, 200mg, 400mg |
| Medical Code | M01AH01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes